“…The filtrate was concentrated under reduced pressure and the remaining residue was purified by silica gel column chromatography (hexanes-AcOEt=10 : 1) and HPLC (Senshu Pak PEGASIL-B 20ϕ×250 nm, MeOH/H 2 O (0.1% TFA)=90/10, flaw rate 10 mL/min) to give α-18 (215 mg, 63%) and β-18 (47.8 mg, 14%) as colorless syrups. 26) (245 mg, 1.25 mmol, prepared from 19 as indicated in Chart 6 in this work) and 1-butyl-3-methylimidazolium chloride (bmimCl) (59.4 mg, 0.34 mmol) were added. The resulting solution was stirred at reflux condition for 3 h. After evaporation, the resulting residue was purified by silica gel column chromatography (hexanes-AcOEt=10 : 1) to afford 21 as a colorless amorphous (65.8 mg, 21% yield Sodium 1-O-(2,3,4-Tri-O-benzyl-6-sulfo-α-D-quinovopyranosyl)-3-O-p-methoxybenzyl-propane-1,3-diol (23) Oxone ® was added to a suspension of α-18 (161 mg, 0.23 mmol) and sodium acetate (390 mg, 0.48 mmol) in acetic acid (3.4 mL) and the resulting mixture was stirred at room temperature for 24 h. The mixture was then diluted with AcOEt and washed with saturated NaHCO 3 aq., and brine, dried over Na 2 SO 4 , filtered and concentrated under reduced pressure.…”